Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Per Dahl Christensen"'
Autor:
Christian Jøns, Poul Erik Bloch Thomsen, Sam Riahi, Tom Smilde, Ulrich Bach, Peter Karl Jacobsen, Miloš Táborský, Jozsef Faluközy, Marcus Wiemer, Per Dahl Christensen, Attila Kónyi, Dan Schelfaut, Alan Bulava, Marcin Grabowski, Béla Merkely, Dieter Nuyens, Rajiv Mahajan, Patrick Nagel, Roland Tilz, Jerzy Malczynski, Clemens Steinwender, Johannes Brachmann, Harvey Serota, Jürgen Schrader, Steffen Behrens, Peter Søgaard
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
ObjectivesCardiac arrhythmias predict poor outcome after myocardial infarction (MI). We studied if arrhythmia monitoring with an insertable cardiac monitor (ICM) can improve treatment and outcome.DesignBIO|GUARD-MI was a randomized, international ope
Externí odkaz:
https://doaj.org/article/5cdccb0ebafe4e57b92767dd59e413d1
Publikováno v:
Acta Medica Scandinavica. 220:285-288
A 23-year-old female with extreme hypercalcaemia was treated with calcitonin, mitramycin and parathyroidectomy and normocalcaemia was achieved after 4 weeks. Nevertheless, the patient later died of cutaneous necrosis, impaired circulation and multipl
Publikováno v:
Ugeskrift for laeger. 167(37)
Publikováno v:
The Journal of invasive cardiology. 17(3)
To measure and compare the results of changing from routine transfemoral to routine transradial coronary angiography performed by a single operator.A learning period of 3 months for the transradial procedure with 43 selected patients was followed by
Publikováno v:
Diabetes Care. 19:1135-1137
OBJECTIVE To compare the frequency of thrombolytic therapy in diabetic and nondiabetic patients with acute myocardial infarction (MI) and to examine why some diabetic patients do not receive thrombolytic therapy. RESEARCH DESIGN AND METHODS Retrospec
Autor:
Søen Christensen Kjørgaard, Inge Bülow, Lars Fog, Hans-Henrik Tilsted Hansen, Per Dahl Christensen
Publikováno v:
Diabetes Care. 20:906-907
Autor:
Per Dahl Christensen, Jørgen Ingerslev, Jens Sandahl Christiansen, Stener Stenbierg, Niels Møller, Hans Ørskov
Publikováno v:
The Journal of diabetic complications. 3(2)
Excess production of growth hormone (GH) in poorly controlled diabetes is believed to be a causal factor in the development of diabetic angiopathy, the mechanism(s) of which is unknown. The present study was undertaken to determine whether exogenous